1. Home
  2. FLGT vs TCPC Comparison

FLGT vs TCPC Comparison

Compare FLGT & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • TCPC
  • Stock Information
  • Founded
  • FLGT 2011
  • TCPC 2006
  • Country
  • FLGT United States
  • TCPC United States
  • Employees
  • FLGT N/A
  • TCPC N/A
  • Industry
  • FLGT Medical Specialities
  • TCPC Finance/Investors Services
  • Sector
  • FLGT Health Care
  • TCPC Finance
  • Exchange
  • FLGT Nasdaq
  • TCPC Nasdaq
  • Market Cap
  • FLGT 697.3M
  • TCPC 603.8M
  • IPO Year
  • FLGT 2016
  • TCPC 2012
  • Fundamental
  • Price
  • FLGT $23.00
  • TCPC $5.92
  • Analyst Decision
  • FLGT Buy
  • TCPC Sell
  • Analyst Count
  • FLGT 3
  • TCPC 2
  • Target Price
  • FLGT $25.33
  • TCPC $6.75
  • AVG Volume (30 Days)
  • FLGT 228.6K
  • TCPC 836.2K
  • Earning Date
  • FLGT 11-07-2025
  • TCPC 11-05-2025
  • Dividend Yield
  • FLGT N/A
  • TCPC 20.56%
  • EPS Growth
  • FLGT N/A
  • TCPC N/A
  • EPS
  • FLGT N/A
  • TCPC N/A
  • Revenue
  • FLGT $303,223,000.00
  • TCPC $239,535,768.00
  • Revenue This Year
  • FLGT $15.19
  • TCPC N/A
  • Revenue Next Year
  • FLGT $10.58
  • TCPC N/A
  • P/E Ratio
  • FLGT N/A
  • TCPC N/A
  • Revenue Growth
  • FLGT 4.31
  • TCPC 3.11
  • 52 Week Low
  • FLGT $14.57
  • TCPC $5.93
  • 52 Week High
  • FLGT $23.57
  • TCPC $9.72
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 60.31
  • TCPC 22.16
  • Support Level
  • FLGT $22.05
  • TCPC $6.03
  • Resistance Level
  • FLGT $23.57
  • TCPC $6.17
  • Average True Range (ATR)
  • FLGT 0.68
  • TCPC 0.15
  • MACD
  • FLGT 0.02
  • TCPC -0.04
  • Stochastic Oscillator
  • FLGT 74.94
  • TCPC 0.00

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

Share on Social Networks: